Research + Education
The University of Michigan Rogel Cancer Center has a distinguished history of scientific excellence, collaboration and impact in basic science, clinical research and cancer control research.
News
-
Rogel Cancer Center at AACR Annual Meeting
Rogel Cancer Center faculty and trainees will lead nearly 70 presentations, posters and moderated sessions at the American Association for Cancer Research annual meeting.Read More > -
Michigan Surgical Quality Collaborative Teams with BCBSM Foundation to Improve Colorectal Cancer Surgery Outcomes Statewide
Calista Harbaugh, MS, MD., colon and rectal surgeon and health services researcher, is leading the charge to help reduce as many positive margin instances among Michigan colorectal cancer patients as possible. In 2023, Harbaugh’s “Leveraging the Michigan Surgical Quality Collaborative (MSQC) to Improve Statewide Colorectal Cancer” project was awarded a $50,000 Investigator Initiated Research grant from the Blue Cross Blue Shield of Michigan (BCBSM) Foundation.Read More > -
New advances may lead to prostate cancer treatment with fewer side effects
Within the last few years, nuclear medicine has added to cutting edge treatment options for cancer. One of the latest advancements is the use of a treatment called Pluvicto to treat metastatic castration-resistant prostate cancer.Read More > -
New model of key brain tumor feature could help scientists understand how to develop new treatments
Researchers at the University of Michigan Health Rogel Cancer Center are exploiting a unique biological feature of glioblastoma to gain a better understanding of how this puzzling brain cancer develops and how to target new treatments against it. The team developed human and mouse models of glioblastoma oncostreams and examined multiple factors in the tumor microenvironment that could impact how oncostreams develop and how to reverse them.Read More >
Multimedia + Social Media